Is TAVI Safe? Risks, Recovery and What to Realistically Expect in 2026
TAVI carries real risks — stroke, pacemaker, bleeding — but at high-volume centres, serious complications occur in fewer than 5% of cases. This guide explains every risk honestly, what recovery looks like, and why India's top cardiac centres match global safety benchmarks.
By Gaf Healthcare Editorial Team
2026-05-02
Yes — TAVI is safe at high-volume, experienced centres, with a 30-day procedural success rate of 95–98%. Major stroke occurs in fewer than 2% of patients. The need for a permanent pacemaker arises in 8–15% of cases — a well-managed, expected complication. Untreated severe aortic stenosis kills more than 50% of patients within two years of symptoms. The risk of doing nothing is consistently far higher than the risk of TAVI at a competent centre.
"Is it safe?" is the first question almost every patient asks when TAVI is recommended. It deserves a straight answer rather than reassurance dressed up as information. TAVI carries real risks. So does the alternative — because severe aortic stenosis without treatment is a terminal diagnosis on a timeline measured in months. The right question is not "is TAVI risk-free?" — it never is. The right question is: "Is the risk of TAVI lower than the risk of not having it?" At a skilled centre, the answer is almost always yes. This guide gives you the complete picture.
The Risk That Matters Most: Not Having the Procedure
Before examining TAVI's specific risks, it is essential to place them in context. Untreated severe symptomatic aortic stenosis is among the most dangerous conditions in adult cardiology. The landmark natural history studies established that once symptoms develop — breathlessness, chest pain, or syncope (fainting) — the 2-year mortality without treatment exceeds 50%.
This single fact transforms the risk conversation. A TAVI procedure at a high-volume centre carries a 30-day mortality risk of approximately 1–2%. The disease itself, if untreated, kills the majority of patients within 24 months. Every honest discussion of TAVI safety must begin here — with the recognition that watchful waiting for symptomatic severe aortic stenosis is not a safe alternative. It is a trajectory.
Important context: "High-risk" in TAVI refers to the patient's surgical risk for open-heart surgery — not to the risk of TAVI itself. A patient who is high-risk for conventional surgery may be an ideal TAVI candidate precisely because TAVI avoids the factors that make open surgery dangerous for them. See our complete TAVI eligibility guide for the full breakdown.
The Real Risks of TAVI: What the Data Actually Shows
Every patient deserves an honest account of the risks associated with the procedure being recommended. The following data is drawn from published trial registries including PARTNER 3, Evolut Low Risk, and the TVT (Transcatheter Valve Therapy) registry, which tracks real-world TAVI outcomes across thousands of patients annually.
| Complication | Frequency (High-Volume Centres) | Context |
|---|---|---|
| Procedural success | 95–98% | Valve deployed correctly, haemodynamically functioning at discharge |
| 30-day mortality | 1–2% | Lower in low-risk patients; higher in high-risk or complex anatomy |
| Major stroke | <2% | Comparable to open surgery; cerebral embolic protection devices can reduce this further |
| Permanent pacemaker (PPM) | 8–15% | Self-expanding valves (Evolut) have higher rates than balloon-expandable (Sapien). Expected, manageable. |
| Major vascular complication | 2–5% | Bleeding, haematoma, or vessel injury at the femoral access site; usually manageable |
| Significant paravalvular leak | <3% (moderate/severe) | Rare with modern valve generations (Sapien 3 Ultra, Evolut FX). Mild trace PVL is common and benign. |
| Coronary obstruction | <1% | Rare; identified and managed pre-procedurally through CT coronary height measurement |
| Acute kidney injury (temporary) | 3–5% | Related to contrast agent used during the procedure; typically transient and reversible |
Volume matters more than geography: The single most powerful predictor of TAVI safety outcomes is the annual case volume of the centre performing the procedure. Centres performing 200+ TAVI procedures per year consistently demonstrate lower complication rates, faster procedure times, and better valve positioning accuracy. India's top centres — Fortis Escorts, Medanta, Apollo — all qualify as high-volume by international benchmarks.
The Pacemaker Question: Why 1 in 10 Patients Needs One — and Why It Is Not a Failure
The need for a permanent pacemaker after TAVI is the complication that concerns patients most — and the one that is most frequently misunderstood. It is not a sign that something went wrong. It is a consequence of the anatomy of the heart's electrical conduction system, which runs very close to the aortic valve annulus.
When the new transcatheter valve is deployed, it can exert pressure on the bundle of His — the electrical highway that coordinates the lower chambers of the heart. In 8–15% of patients (higher with self-expanding valves like Medtronic Evolut), this produces a conduction disturbance significant enough to require a pacemaker. The pacemaker is implanted during the same hospital stay by an electrophysiology team. It is a planned contingency, not a rescue.
This is precisely why patients are monitored for 48–72 hours post-TAVI before discharge. The need for a pacemaker almost always becomes apparent within this window. It is also why GAF Healthcare recommends that international patients remain in India for a minimum of 10–14 days after TAVI — to allow this monitoring period to conclude safely before flying home.
TAVI vs Open Surgery: How the Safety Profiles Compare
For patients weighing their options, a direct safety comparison between TAVI and surgical aortic valve replacement (SAVR) is the most informative framework. The table below summarises outcomes from the landmark low-risk trials, where both procedures were performed at high-volume expert centres. For a deeper procedure-by-procedure comparison, see our TAVI vs angioplasty vs bypass surgery guide.
| Outcome | TAVI (Low-Risk Trials) | Open Surgery (SAVR) |
|---|---|---|
| 30-day mortality | 0.5–1.0% | 1.1–1.7% |
| Major stroke (30-day) | 0.6–1.2% | 1.1–2.5% |
| Major bleeding | 3–5% | 10–25% |
| Atrial fibrillation (new) | 5–8% | 30–40% |
| New permanent pacemaker | 8–15% | 2–5% |
| Wound infection / chest complication | Rare (no chest opening) | 3–8% |
| Hospital stay | 3–4 days | 7–10 days |
The data tells a clear story: TAVI's advantages are most pronounced in the areas of bleeding, atrial fibrillation, wound complications, and hospital stay. Open surgery has a modest advantage in pacemaker rates. The two approaches are broadly equivalent in mortality and stroke at experienced centres — with TAVI increasingly favoured as the default choice across risk groups. This is why the future of heart valve replacement is firmly transcatheter.
Understand Your Personal TAVI Risk Profile — Free in 24 Hours
Send your echocardiogram and CT to GAF Healthcare. Our structural cardiologist calculates your specific procedural risk and explains it clearly — before you commit to anything.
Get My Free Risk Assessment →💬 WhatsApp +91 90443 46292
How Centres in India Make TAVI Safer: Technology and Protocols
India's leading cardiac hospitals have invested specifically in the infrastructure that reduces TAVI complication rates. This is not generic hospital quality — it is the specific combination of technology, team structure, and volume that defines a safe TAVI programme.
TAVI Recovery: A Day-by-Day Guide to What to Expect
Recovery from TAVI is dramatically faster than open surgery — but it is not instant, and international patients in particular need a realistic framework. Here is what the typical recovery looks like for a transfemoral TAVI at an Indian centre.
Long-Term Safety: What Happens After You Leave the Hospital?
TAVI safety extends beyond the procedure itself. The long-term performance of the transcatheter valve is a legitimate and increasingly well-answered question as more patients reach the 5, 7, and 10-year follow-up milestones of the landmark trials.
People Also Ask: TAVI Safety Questions Answered
The Honest Conclusion: Safe Enough — at the Right Centre
TAVI is not risk-free. No cardiac procedure is. But the data, gathered across tens of thousands of patients in the most rigorous clinical trials ever conducted in structural heart disease, consistently shows that TAVI at a high-volume centre is among the safest major cardiac interventions available — and dramatically safer than the condition it treats if left alone.
The risk of stroke is under 2%. The risk of death from the procedure at experienced centres is under 2%. The improvement in quality of life — the ability to walk without breathlessness, to sleep without fear — begins the morning after the procedure. Recovery is measured in weeks, not months. And the cost in India, using the same devices and matching the same outcomes, is a fraction of what the procedure costs in Western healthcare systems. For more on that dimension, see our full TAVI cost comparison guide.
Send Your Reports — Free TAVI Safety & Eligibility Review in 24 Hours
Send your echocardiogram and CT to GAF Healthcare. Our structural cardiologist will assess your specific risk profile, explain the procedure honestly, and recommend the right centre for your anatomy — completely free.
Get My Free TAVI Assessment →💬 WhatsApp +91 90443 46292
Statistical data cited is drawn from published clinical trial registries including PARTNER 3, Evolut Low Risk, NOTION, and the TVT Registry. Individual patient outcomes vary based on anatomy, comorbidities, and centre volume. This article is for informational purposes only and does not constitute medical advice. All clinical decisions should be made in consultation with a qualified cardiologist. GAF Healthcare is a medical facilitation service and does not provide clinical care directly.